HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.

Abstract
Benztropine (BZT) analogs, a family of high-affinity dopamine transporter ligands, are molecules that exhibit pharmacological and behavioral characteristics predictive of significant therapeutic potential in cocaine addiction. Here, we examined in mice the effects of 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane (AHN-1055) on motor activity, conditioned place preference (CPP) and c-Fos expression in the striatum. AHN-1055 produced mild attenuation of spontaneous locomotor activity at a low dose (1 mg/kg) and weak stimulation at a higher dose (10 mg/kg). In parallel, the BZT analog significantly increased c-Fos expression in the dorsolateral caudoputamen at the high dose, whereas producing marginal decreases at low and moderate doses (1, 3 mg/kg) in both dorsal and ventral striatum. Interaction assays showed that cocaine's ability to stimulate locomotor activity was decreased by AHN-1055 treatment, but not by treatment with D-amphetamine. Such reduced ability did not result from an increase in stereotyped behavior. Another dopamine uptake inhibitor, nomifensine, decreased cocaine-induced locomotor activity but evoked by itself intense motor stereotypies. Remarkably, the BZT analog dose-dependently blocked cocaine-induced CPP without producing CPP when given alone, and blocked in conditioned mice cocaine-stimulated early-gene activation in the nucleus accumbens and dorsomedial striatum. These observations provide evidence that AHN-1055 does not behave as a classical psychomotor stimulant and that some of its properties, including attenuation of cocaine-induced striatal c-Fos expression, locomotor stimulation, and CPP, support its candidacy, and that of structurally related molecules, as possible pharmacotherapies in cocaine addiction.
AuthorsClara Velázquez-Sánchez, Antonio Ferragud, Vicente Hernández-Rabaza, Amparo Nácher, Virginia Merino, Miguel Cardá, Juan Murga, Juan J Canales
JournalNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (Neuropsychopharmacology) Vol. 34 Issue 12 Pg. 2497-507 (Nov 2009) ISSN: 1740-634X [Electronic] England
PMID19606084 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dopamine Uptake Inhibitors
  • N-methyl-3-(bis(4'-fluorophenyl)methoxy)tropane
  • Proto-Oncogene Proteins c-fos
  • Nomifensine
  • Benztropine
  • Cocaine
Topics
  • Animals
  • Benztropine (administration & dosage, analogs & derivatives, pharmacology)
  • Brain (drug effects, metabolism)
  • Cocaine (pharmacology)
  • Cocaine-Related Disorders (drug therapy)
  • Conditioning, Classical (drug effects)
  • Dopamine Uptake Inhibitors (administration & dosage, pharmacology)
  • Dose-Response Relationship, Drug
  • Gene Expression (drug effects)
  • Male
  • Mice
  • Motor Activity (drug effects)
  • Nomifensine (pharmacology)
  • Proto-Oncogene Proteins c-fos (metabolism)
  • Reward
  • Space Perception (drug effects)
  • Stereotyped Behavior (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: